
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Based on iTunes & Spotify (publisher stats).
- Per-Episode Audience
Est. listeners per new episode within ~30 days
1,001 - 10,000 - Monthly Reach
Unique listeners across all episodes (30 days)
5,001 - 25,000 - Active Followers
Loyal subscribers who consistently listen
5,001 - 15,000
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 10 epsHosts
Recent guests
Recent episodes
Healthcare Will Benefit Most from AI | Julie Yoo on StartUp Health
Apr 21, 2026
28m 33s
Andrew Huberman: Peptides, Sleep Tech, and the End of Obesity
Mar 9, 2026
51m 32s
Rebuilding Behavioral Health’s Operating System with AI
Mar 2, 2026
36m 31s
AI in Healthcare: The Leapfrog Opportunity
Feb 24, 2026
25m 59s
Ambience CEO Nikhil Buduma on AI in Clinical Workflows
Feb 20, 2026
49m 10s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 4/21/26 | Healthcare Will Benefit Most from AI | Julie Yoo on StartUp Health✨ | AI in healthcarehealth tech+3 | Julie Yoo | a16zStartUp Health | — | healthcareAI+3 | — | 28m 33s | |
| 3/9/26 | Andrew Huberman: Peptides, Sleep Tech, and the End of Obesity✨ | peptidessleep technology+5 | Dr. Andrew Huberman | Stanford UniversityHuberman Lab | — | peptidessleep tech+5 | — | 51m 32s | |
| 3/2/26 | Rebuilding Behavioral Health’s Operating System with AI✨ | behavioral healthAI technology+4 | Zach CohenRaymond Wang | Ease Healtha16z | — | behavioral healthAI operating system+4 | — | 36m 31s | |
| 2/24/26 | AI in Healthcare: The Leapfrog Opportunity✨ | AI in healthcaretechnology investment+3 | Julie Yoo | a16z Bio + HealthOliver Wyman | — | AIhealthcare+5 | — | 25m 59s | |
| 2/20/26 | Ambience CEO Nikhil Buduma on AI in Clinical Workflows✨ | AIclinical workflows+3 | Nikhil Buduma | Ambience Healthcare | — | AIclinical workflows+5 | — | 49m 10s | |
| 2/17/26 | Building the Marketplace for AI’s Most Valuable Asset✨ | AIhealthcare+4 | Bobby Samuels | ProtegeAI+3 | — | AIreal-world data+5 | — | 38m 41s | |
| 2/5/26 | Making Healthcare Affordable for 80 Million Americans✨ | healthcare affordabilityAI in healthcare+3 | Nikita SingareddyFlorian Otto | FortunaCedar+1 | — | healthcareaffordability+6 | — | 37m 10s | |
| 1/27/26 | ![]() Healthcare 2026: AI Doctors, GLP-1s, and Insurance Defection✨ | healthcareAI+3 | Nikhil Krishnan | Out-of-Pocketa16z+1 | — | healthcare educationAI doctors+3 | — | 1h 34m 02s | |
| 1/8/26 | Building AI Foundation Models for Molecular Design✨ | AI in molecular biologydrug discovery+3 | Jeremy WohlwendGabriele Corso | BoltzAlphaFold+3 | — | AImolecular design+5 | — | 47m 02s | |
| 12/4/25 | How AI Cut Healthcare Burnout by 70%✨ | AI in healthcarephysician burnout+3 | Peter McCanna | Baylor Scott & White Healtha16z | — | AIhealthcare burnout+5 | — | 47m 31s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 11/24/25 | ![]() The Future of Healthcare Payments: CMS Chief of Staff Stephanie Carlton | A labor and delivery nurse who ran Senate healthcare policy now manages $1.7 trillion in federal health spending—and she runs her team like a startup. Steph Carlton, Chief of Staff and Deputy Administrator at CMS, reveals the OKRs driving Medicare and Medicaid, why they're killing social determinants funding while building consumer health apps at scale, and how real-time provider data could collapse the 18-month lag between care delivery and payment. The team mixing founders with policy veterans is rewriting quality measures around VO2 max and app engagement, not just disease management—because preventing illness years before it happens might finally be worth more than treating it after. | — | ||||||
| 11/17/25 | ![]() How to Build This Generation's Big Pharma Company | Drug discovery has doubled the flow of candidates, but approvals remain roughly flat. The constraint is development, not discovery. In this episode, a16z General Partner, Jorge Conde talks with Formation Bio cofounder and CEO Ben Liu about building a modern pharma company around clinical execution. They discuss Formation Bio’s hub-and-spoke model for acquiring and advancing assets, how AI compresses trial timelines and costs, picking winners, regulatory strategy, and what it would take to move from about 50 approvals a year to many more. They also touch on global competition and why clinical proof still drives value in today’s market. | — | ||||||
| 11/10/25 | ![]() CVS Health: Building Healthcare’s Consumer Platform | Josh Weiner left Meta to return to CVS Health with two painful realizations: consumers don't manage their health—they expect it, and the healthcare market fundamentally violates every principle of economics. In this conversation with a16z's Julie Yoo, the CVS Senior VP explains why 50% of Americans can't afford a healthcare emergency, how CVS is becoming a platform to solve structural healthcare problems, and why the future depends on consumers finally controlling their own health data. | — | ||||||
| 11/7/25 | ![]() Dyno Therapeutics: Empowering Patients with Genetic Agency | For the first time in human history, we can diagnose thousands of genetic diseases—often for under $1,000—but we still can't treat most of them. The problem isn't understanding what's broken; it's delivering the fix to the right cells. Eric Kelsic, CEO of Dyno Therapeutics, joins a16z's Jorge Conde to explain how AI-designed protein shells are solving gene therapy's delivery crisis. They explore why Huntington's patients can now get 15 extra years of healthy life, how Dyno inverted the liver-to-brain delivery ratio by 1000x, and why capsids evolved by nature are now being designed by machine learning models trained on millions of variants. Eric introduces the concept of genetic agency—humanity's first-ever ability to take action at the DNA level—and details why solving delivery for common diseases will make ultra-rare disease treatments economically viable. Plus: what happens when gene therapy requires neurosurgery today but could be a simple injection tomorrow, why recent deaths in clinical trials prove we need better technology now, and how genetic medicine could become as routine as surgery within our lifetimes. | — | ||||||
| 9/29/25 | ![]() Value-Based Oncology at Scale: Inside Thyme Care | Cancer care in the U.S. costs over $250 billion each year, and nearly 2 million Americans receive a new diagnosis annually, yet too often the journey begins with silence: no call, no plan, no guide. In this episode, a16z’s Vineeta Agarwala and Jay Rughani talk with Thyme Care leaders Robin Shah (cofounder and CEO), Bobby Green, MD (president and CMO), and Brad Diephuis, MD (president and COO) about rebuilding oncology around the patient. They cover where the system breaks, how navigation plus value-based contracts align incentives, how AI can extend clinicians, and what scale looks like today, more than 83,000 active patients. A concise blueprint for truly patient-centered cancer care. | — | ||||||
| 8/6/25 | ![]() The Consumer Becomes the Payor: How ICHRA Unlocks a New Era in Healthcare | In this episode, Julie Yoo and Jay Rughani are joined by Thatch cofounders Chris Ellis and Adam Stevenson to explore why ICHRA—a more recent policy innovation—might quietly revolutionize employer-sponsored health benefits. | — | ||||||
| 7/22/25 | ![]() Engaging the Unengaged at Home with Max Cohen and Cameron Behar | In this episode, Sprinter Health co-founders Max Cohen and Cameron Behar sit down with Julie Yoo to unpack how their home-based care model reaches underserved populations and reintegrates “the unengaged” into the healthcare system. | — | ||||||
| 6/20/25 | ![]() Streamlining the Patient Referrals Chain with Trey Holterman | In this episode, Tennr cofounder and CEO Trey Holterman sits down with a16z’s David Haber and Jay Rughani to unpack one of healthcare’s most overlooked pain points: patient referral logistics. | — | ||||||
| 6/10/25 | ![]() From Chaos to Clarity in Data with Malinka Walaliyadde | Malinka Walaliyadde, cofounder and CEO of AKASA, joins Julie Yoo to unpack how large language models have the potential to transform hospital revenue by automating highly nuanced coding and billing workflows. | — | ||||||
| 5/27/25 | ![]() Superaging with Eric Topol | What if we stopped trying to cure disease and started preventing it instead? In this episode, Eric Topol joins general partner Vijay Pande to unpack the future of aging, prevention, and precision health—as explored in Eric's new book, Super Agers: An Evidence-Based Approach to Longevity. | — | ||||||
| 5/13/25 | ![]() Fueling Innovation with Data with Arif Nathoo | Arif Nathoo, cofounder and CEO of Komodo Health, joins Jorge Conde and Jay Rughani of a16z Bio + Health. | — | ||||||
| 4/29/25 | ![]() The Paradox of U.S. Healthcare with Marc Andreessen | Marc Andreessen joins Julie Yoo and Vijay Pande. | — | ||||||
| 4/15/25 | ![]() The (Epic) Arc of a Patient Journey with Seth Hain | Seth Hain, SVP of R&D at Epic, joins a16z Bio + Health general partner Julie Yoo. | — | ||||||
| 4/1/25 | ![]() Building for the Healthcare Consumer with Elliot Cohen | Elliot Cohen, cofounder of PillPack, joins Julie Yoo, a16z Bio + Health general partner. | — | ||||||
| 3/11/25 | ![]() Scaling Mental Health Access through AI with Neil Parikh and Daniel Cahn | Neil Parikh and Daniel Cahn, cofounders of Slingshot AI, join Julie Yoo, general partner at a16z Bio + Health. | — | ||||||
Showing 25 of 200
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
28 placements across 23 markets.
Chart Positions
28 placements across 23 markets.












